Defense of GlaxoSmithKline in Avandia Litigation

We assisted GlaxoSmithKline (GSK) with defense of the litigation by serving as one of their science counsel, working with the medical literature and experts. We reviewed the pertinent medical literature and retained experts in both cardiology and diabetes to assist in the defense of these cases.

You Also May Be Interested In:

  • Representation of Mallinckrodt Pharmaceuticals, a global pharmaceutical manufacturer, in numerous cases in courts across Tennessee, Kentucky, and Virginia

    Bass, Berry & Sims represents Mallinckrodt Pharmaceuticals, a global pharmaceutical manufacturer, in numerous cases in courts across Tennessee, Kentucky, and...
    Client Type: Public Company
  • Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management.  Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.

    We served as lead legal counsel to POINT Biopharma Inc., a late stage biopharmaceutical company dedicated to bringing the many...
    Client Type: Private Company
  • Represented Boston Children’s Hospital with intellectual property, business, and government contracting issues associated with VaccineFinder

    We represented Boston Children's Hospital with intellectual property, business, and government contracting issues associated with VaccineFinder. We also assisted Boston...
    Client Type: Private Company